C J Newton
Overview
Explore the profile of C J Newton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
464
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Seddon A, Green V, Newton C, Greenman J, Atkin S, Speirs V
In Vitro Cell Dev Biol Anim
. 1998 Oct;
34(9):677-8.
PMID: 9794218
No abstract available.
12.
Cornbrooks E, Newton C, Forehand C
J Comp Neurol
. 1997 May;
382(1):1-18.
PMID: 9136808
Sympathetic preganglionic axons project to spatially distinct targets in the periphery. A precise topographic pattern exists within the thoracic preganglionic cell column relative to the direction of axonal projections within...
13.
Behl C, Skutella T, Lezoualch F, Post A, Widmann M, Newton C, et al.
Mol Pharmacol
. 1997 Apr;
51(4):535-41.
PMID: 9106616
Oxidative stress-induced neuronal cell death has been implicated in different neurological disorders and neurodegenerative diseases; one such ailment is Alzheimer's disease. Using the Alzheimer's disease-associated amyloid beta protein, glutamate, hydrogen...
14.
Newton C
J Steroid Biochem Mol Biol
. 1995 Dec;
55(3-4):327-36.
PMID: 8541229
Our previous studies have shown that even in the absence of estrogen, the estrogen receptor (ER) is still involved in growth by way of its conversion to a transcriptionally active...
15.
Pagotto U, Arzberger T, Hopfner U, Sauer J, Renner U, Newton C, et al.
J Clin Invest
. 1995 Oct;
96(4):2017-25.
PMID: 7560095
In addition to its well-known homoeostatic actions in the cardiovascular system, ET-1 has been shown to constitute a potent growth regulatory peptide in various tissues. We have studied the expression...
16.
Renner U, Newton C, Pagotto U, Sauer J, Arzt E, Stalla G
Endocrinology
. 1995 Aug;
136(8):3186-93.
PMID: 7628350
Interleukin-1 (IL-1), one of the mediators of the interaction between the immune and the neuroendocrine system, is well known to modulate anterior pituitary hormone secretion. As IL-1 influences growth of...
17.
WATKINS W, Winstanley P, Mberu E, Kokwaro G, Murphy S, Newton C, et al.
Br J Clin Pharmacol
. 1995 Mar;
39(3):283-7.
PMID: 7619670
1. Kenyan children with uncomplicated malaria given oral halofantrine (HF; non-micronised suspension; 8 mg base kg-1 body weight 6 hourly for three doses) showed wide variation in the disposition of...
18.
Newton C, Arzt E, Stalla G
Biochem Biophys Res Commun
. 1994 Dec;
205(3):1930-7.
PMID: 7811284
Having recently demonstrated in separate studies that the T-cell cytokine, interleukin-2, induces the growth of the pituitary tumor cell line GH3 and that in the same cells, the estrogen receptor...
19.
Newton C, Trapp T, Pagotto U, Renner U, Buric R, Stalla G
J Mol Endocrinol
. 1994 Jun;
12(3):303-12.
PMID: 7916969
The GH3 pituitary cell line has been used to investigate the role of the oestrogen receptor (ER) as a modulator of mitogenic signals in tumour cells in the absence of...
20.
Newton C, Buric R, Trapp T, Brockmeier S, Pagotto U, Stalla G
J Steroid Biochem Mol Biol
. 1994 Apr;
48(5-6):481-6.
PMID: 8180109
In the absence of serum and estrogen, we show that the growth of the prolactin secreting pituitary tumour cell line, GH3 is stimulated by insulin and insulin-like growth factor-1 (IGF-1)...